In last trading session, Ideaya Biosciences Inc (NASDAQ:IDYA) saw 2.15 million shares changing hands with its beta currently measuring 0.29. Company’s recent per share price level of $16.35 trading at $1.58 or 10.70% at ring of the bell on the day assigns it a market valuation of $1.43B. That closing price of IDYA’s stock is at a discount of -171.68% from its 52-week high price of $44.42 and is indicating a premium of 11.93% from its 52-week low price of $14.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.33 million shares which gives us an average trading volume of 938.75K if we extend that period to 3-months.
For Ideaya Biosciences Inc (IDYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.17. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Ideaya Biosciences Inc (NASDAQ:IDYA) trade information
Upright in the green during last session for gaining 10.70%, in the last five days IDYA remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $16.35 price level, adding 9.07% to its value on the day. Ideaya Biosciences Inc’s shares saw a change of -36.38% in year-to-date performance and have moved -6.25% in past 5-day. Ideaya Biosciences Inc (NASDAQ:IDYA) showed a performance of -12.99% in past 30-days. Number of shares sold short was 9.88 million shares which calculate 10.31 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 38.5 to the stock, which implies a rise of 57.53% to its current value. Analysts have been projecting 27 as a low price target for the stock while placing it at a high target of 50. It follows that stock’s current price would drop -65.14% in reaching the projected high whereas dropping to the targeted low would mean a loss of -65.14% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -0.01% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 16.94% while estimates for its earnings growth in next 5 years are of 15.86%.
Ideaya Biosciences Inc (NASDAQ:IDYA)’s Major holders
Insiders are in possession of 1.04% of company’s total shares while institution are holding 109.50 percent of that, with stock having share float percentage of 110.65%. Investors also watch the number of corporate investors in a company very closely, which is 109.50% institutions for Ideaya Biosciences Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at IDYA for having 11.27 million shares of worth $395.69 million. And as of 2024-06-30, it was holding 14.4557 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 6.81 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.7321 of outstanding shares, having a total worth of $239.02 million.
